4//SEC Filing
GAUGLER DARYL 4
Accession 0001209191-22-035221
CIK 0001396814other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:24 PM ET
Size
13.3 KB
Accession
0001209191-22-035221
Insider Transaction Report
Form 4
GAUGLER DARYL
Chief Operating Officer
Transactions
- Award
Common Stock
2022-06-08+5,000→ 24,394 total - Sale
Common Stock
2022-06-06$61.37/sh−1,106$67,880→ 11,494 total - Award
Common Stock
2022-06-08+7,900→ 19,394 total - Award
Stock Option (Right to Buy)
2022-06-08+19,800→ 19,800 totalExercise: $59.39Exp: 2032-06-08→ Common Stock (19,800 underlying) - Award
Stock Option (Right to Buy)
2022-06-08+10,000→ 10,000 totalExercise: $59.39Exp: 2032-06-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F3]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001928278
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:24 PM ET
- Size
- 13.3 KB